Overview

Update
Total Equity Funding
$4.1M in 1 Round from 2 Investors
Most Recent Funding
$4.1M Venture on March 29, 2007
Headquarters:
Çan, Canakkale
Description:
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with Type II Diabetes.
Categories:
Biotechnology
Website:
http://prognomix.com

Company Details

Update
Founded:
2005
Contact:
514-529-9757
Employees:
None found in Crunchbase

Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.

Funding Rounds (1) - $4.1M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2007$4.1M / Venture2

Investors (2)

Board Members and Advisors (1)

Update

News (1)

Update
DateNews
Mar 17, 2010bdc.ca - Prognomix raises 4100000 in unknown round

Offices/Locations (1)

Update
  • Office

    4101, rue Molson, bureau 201

    Montreal (Quebec)

    Çan, Canakkale H1Y 3L1

    Turkey

Images (1)

Update

Add Acquisitions

Add Current Team

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos